Sign in

NCT05784246CompletedPhase 3

A Study of Mirikizumab (LY3074828) in Pediatric Participants With Moderately to Severely or Active Ulcerative Colitis

A Multicenter, Phase 3, Open-Label Study to Investigate the Efficacy, Pharmacokinetics, and Safety of Mirikizumab in Participants 2 Years to Less Than 18 Years of Age With Moderately to Severely Active Ulcerative Colitis

Source: ClinicalTrials.gov · Last updated 3 Jun 2026

Brief summary (registry, in English)

The main purpose of this study is to investigate efficacy, pharmacokinetics and safety of the drug in pediatric participants with moderately to severely active ulcerative colitis (UC).

Status (registry)
Completed
Phase (registry)
Phase 3
Study type
Interventional
Enrollment
63 (actual)
First submitted
13 Mar 2023
Start date
22 Nov 2023
Primary completion date
1 May 2026
Lead sponsor
Eli Lilly and Company
NCT number
NCT05784246
EU CT number
2022-502183-20-00

What you commit to

  • Study type: Interventional · Phase 3
  • Participants enrolled: 63
  • From 22 Nov 2023 to the primary completion date, 1 May 2026
  • 41 sites in 13 countries
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Previous bowel resection or intestinal surgery.

Other illness

  • Have Crohn's disease, Inflammatory Bowel Disease Unclassified, ulcerative proctitis or primary sclerosing cholangitis.
  • Have immune deficiency syndrome.
  • History or current evidence of cancer of the gastrointestinal tract.

Other

  • Evidence of toxic megacolon.

Who the study is looking for

  • Males or females weighing ≥10 kg and ≥2 and \<18 years old at the time of consent for screening.
  • Have moderate to severe UC.
  • Have failed corticosteroids, biologics, (for example, anti-tumor necrosis factor (TNF) antibodies or anti-integrin antibodies), immunomodulators (for example, azathioprine, thiopurines or methotrexate) or Janus Kinase (JAK)-Inhibitor treatment.
  • Have UC at least 3 months in duration before baseline, which includes endoscopic evidence of UC corroborated by a histopathology report.

Age in the registry: 2 years to 17 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (41)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Antwerp University Hospital
Coordinator of this site? Confirm its status
EdegemBelgiumCompleted
UZ Leuven
Coordinator of this site? Confirm its status
LeuvenBelgiumCompleted
The Hospital for Sick Children
Coordinator of this site? Confirm its status
TorontoCanadaUnknown status
Universitaetsmedizin Der Johannes Gutenberg-Universitaet Mainz Koerperschaft Des Offentlichen Rechts
Coordinator of this site? Confirm its status
MainzGermanyCompleted
Klinikum der Universitaet Muenchen AöR
Coordinator of this site? Confirm its status
MunichGermanyCompleted
Helios Universitaetsklinikum Wuppertal
Coordinator of this site? Confirm its status
WuppertalGermanyCompleted
Centre Hospitalier Universitaire Amiens Picardie
Coordinator of this site? Confirm its status
Amiens Cedex 1FranceCompleted
Hospices Civils de Lyon
Coordinator of this site? Confirm its status
BronFranceCompleted
Assistance Publique Hopitaux de Paris
Coordinator of this site? Confirm its status
ParisFranceCompleted
Sheffield Children's Hospital
Coordinator of this site? Confirm its status
SheffieldUnited KingdomUnknown status
Hadassah University Hospital - Ein Kerem
Coordinator of this site? Confirm its status
JerusalemIsraelUnknown status
Shaare Zedek
Coordinator of this site? Confirm its status
JerusalemIsraelUnknown status
Schneider Children's Medical Center
Coordinator of this site? Confirm its status
Petah TikvaIsraelUnknown status
King Fahad Medical City
Coordinator of this site? Confirm its status
Rishon LeZiyyonIsraelUnknown status
Azienda Ospedaliera Universitaria Meyer IRCCS
Coordinator of this site? Confirm its status
FlorenceItalyCompleted
Ospedale Pediatrico Bambino Gesù
Coordinator of this site? Confirm its status
RomeItalyCompleted
Azienda Ospedaliero-Universitaria Policlinico Umberto I
Coordinator of this site? Confirm its status
RomeItalyCompleted
Juntendo University Hospital
Coordinator of this site? Confirm its status
Bunkyō CityJapanUnknown status
Institute of Science Tokyo Hospital
Coordinator of this site? Confirm its status
Bunkyō CityJapanUnknown status
Kokikai Tsujinaka Hospital Kashiwanoha
Coordinator of this site? Confirm its status
Kashiwa-shiJapanUnknown status
Saga University Hospital
Coordinator of this site? Confirm its status
SagaJapanUnknown status
National Center for Child Health and Development
Coordinator of this site? Confirm its status
Setagaya-KuJapanUnknown status
Yokohama City University Medical Center, Center of IBD
Coordinator of this site? Confirm its status
YokohamaJapanUnknown status
Kyungpook National University Chilgok Hospital
Coordinator of this site? Confirm its status
DaeguSouth KoreaUnknown status
Severance Hospital, Yonsei University Health System
Coordinator of this site? Confirm its status
SeoulSouth KoreaUnknown status
Samsung Medical Center
Coordinator of this site? Confirm its status
SeoulSouth KoreaUnknown status
Amsterdam UMC
Coordinator of this site? Confirm its status
AmsterdamNetherlandsCompleted
Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)
Coordinator of this site? Confirm its status
RotterdamNetherlandsCompleted
Gabinet Lekarski Bartosz Korczowski
Coordinator of this site? Confirm its status
RzeszówPolandCompleted
Twoja Przychodnia-Szczecinskie Centrum Medyczne Sp. z o. o.
Coordinator of this site? Confirm its status
SzczecinPolandCompleted
Instytut Pomnik Centrum Zdrowia Dziecka
Coordinator of this site? Confirm its status
WarsawPolandCompleted
Medical Network Sp z o o
Coordinator of this site? Confirm its status
WarsawPolandCompleted
Centrum Medyczne Oporow
Coordinator of this site? Confirm its status
WroclawPolandCompleted
CCAB Centro Clinico Academico Braga Associacao
Coordinator of this site? Confirm its status
BragaPortugalCompleted
Centro Hospitalar Universitario Sao Joao E.P.E.
Coordinator of this site? Confirm its status
PortoPortugalCompleted
Children's Center for Digestive Health Care, LLC
Coordinator of this site? Confirm its status
AtlantaUnited StatesUnknown status
Cincinnati Children's Hospital Medical Center
Coordinator of this site? Confirm its status
CincinnatiUnited StatesUnknown status
Riley Childrens Hospital
Coordinator of this site? Confirm its status
IndianapolisUnited StatesUnknown status
Icahn School of Medicine at Mount Sinai
Coordinator of this site? Confirm its status
New YorkUnited StatesUnknown status
University of California San Francisco
Coordinator of this site? Confirm its status
San FranciscoUnited StatesUnknown status
Washington University
Coordinator of this site? Confirm its status
St LouisUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.